Summary The case began when a man claimed that he got rashes after using the cream. Photo courtesy: NDTV
(Web Desk) - Indian superstar Shah Rukh Khan may have gotten his foot stuck in a strange legal battle after a man from the Indian city of Bhopal filed a case against the Bollywood actor for false advertising of a shaving cream.
According to the Hindustan Times, the man - Rajkumar Pandey, claimed that he developed rashes on his face after he used a shaving cream that had been endorsed by the actor. After seeing the rashes Pandey went to a consumer court in Bhopal where he filed the case against Shah Rukh stating that the actor was deliberately misleading people by saying that the shaving cream was “India’s number one”. Pandey also told the court that after using the cream he had developed rashes on his face for which he had to get treatment from a government run hospital.
After hearing the case against Shah Rukh, the court decided to take action and sent out four notices. These were to Khan, the owner of the firm that made the cream, a local shopkeeper and the director of Madhya Pradesh Food and Drugs Department.
i m sorry but this is a total nonsense this individual body reaction and hypersensetivity" allergic reaction "it could happen with fruits
— sandy me (@sandyme15) August 2, 2017
Haha. It s like blaming Ranveer Singh for the pregnancy caused due to failure of Durex!
— Shubha Bhat (@the_anesthetist) August 2, 2017
That was a rash decision .
— The_SMART_ONE (@dirtydesi) August 2, 2017
Many people on social media did not blame Shah Rukh for the man’s rashes
Pandey had claimed that he had gotten the cream tested at the Madhya Pradesh Food and Drugs Department where according to him the report said that “the cream is of low, bad quality.” However, HT claimed it could not verify the veracity of the said report.
Shah Rukh Khan is one of the most famous Indian actors alive and has appeared in more than 80 Bollywood films. Currently he is gearing up for the release of his next film, Jab Harry Met Sejal, which is expected to hit screens this week.
